SI2349204T1 - Delci za vdihavanje, ki vsebujejo tiotropij - Google Patents
Delci za vdihavanje, ki vsebujejo tiotropij Download PDFInfo
- Publication number
- SI2349204T1 SI2349204T1 SI200931854T SI200931854T SI2349204T1 SI 2349204 T1 SI2349204 T1 SI 2349204T1 SI 200931854 T SI200931854 T SI 200931854T SI 200931854 T SI200931854 T SI 200931854T SI 2349204 T1 SI2349204 T1 SI 2349204T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tiotropium
- particles
- stabilizing agent
- pharmaceutical composition
- particle size
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract 17
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title claims abstract 9
- 229940110309 tiotropium Drugs 0.000 title claims abstract 8
- 239000003381 stabilizer Substances 0.000 claims abstract 8
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims abstract 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims abstract 2
- 208000006673 asthma Diseases 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 5
- 239000000725 suspension Substances 0.000 claims 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229960000257 tiotropium bromide Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Electrolytic Production Of Metals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (11)
- DELCI ZA VDIHAVANJE, KI VSEBUJEJO TIOTROPIJ Patentni zahtevki1. Delci za vdihavanje, ki vsebujejo stabilno anhidridno amorfno obliko tiotropija s stabilizacijskim sredstvom, ki je laktoza, pri čemer stabilizirana amorfna oblika tiotropija skupaj s stabilizacijskim sredstvom vključuje matrico, v kateri je tiotropij razpršen v molekularnem stanju ali pri čemer stabilna amorfna oblika tiotropija s stabilizacijskim sredstvom vsebuje amorfen tiotropij razpršen na površino stabilizacijskega sredstva, in pri čemer so delci zmešani z eno ali več grobimi pomožnimi snovmi, ki imajo povprečno velikost delcev 15 do 250 mm.
- 2. Delci za vdihavanje po zahtevku 1, pri čemer tiotropij vsebuje tiotropijev bromid.
- 3. Delci za vdihavanje po kateremkoli izmed zahtevkov od 1 do 2, ki ima povprečno aerodinamično velikost delcev do 10 mm.
- 4. Delci za vdihavanje po zahtevku 1, pri čemer je groba pomožna snov laktoza.
- 5. Farmacevtska zmes, ki vsebuje delce za vdihavanje po zahtevku 1 ali zahtevku 4.
- 6. Farmacevtska zmes po zahtevku 5, pri čemer je vsebnost tiotropijeve baze med 0,02 do 0,8%.
- 7. Farmacevtska zmes po kateremkoli zahtevku od 5 do 6, v obliki kapsul za vdihavanje.
- 8. Farmacevtska zmes po zahtevku 7, pri čemer kapsule vsebujejo hidroksipropilmetilcelulozo.
- 9. Postopek za pripravo delcev za vdihavanje po kateremkoli izmed zahtevkov od 1 do 4, ki vključuje sledeče korake: a. raztapljanje ali razprševanje stabilizacijskega sredstva v hlapnem topilu, ki se dobro meša z vodo, ki po izbiri lahko vsebuje vodo, da nastane raztopina ali suspenzija; b. raztapljanje tiotropijeve soli ali njenega solvata, ali kateremkoli njene trdne oblike, v hlapnem topilu, ki se dobro meša z vodo, ki po izbiri lahko vsebuje vodo; c. mešanje raztopine iz koraka b) in raztopine ali suspenzije iz koraka a); d. sušenje z razprševanje raztopine/suspenzije iz koraka c) da se dobijo želeni delci; in e. mešanje delcev iz koraka d) z enim ali več grobih pomožnih snovi, ki imajo povprečno velikost delcev 15 do 250 mm.
- 10. Postopek po zahtevku 9, pri čemer ko se v koraku a) tvori suspenzija, uporabljeno topilo ne vsebuje vode in je stabilizacijsko sredstvo v obliki delcev, ki imajo povprečno velikost delcev 1 do 9 mm.
- 11. Delci za vdihavanje kot so definirani v kateremkoli izmed zahtevkov od 1 do 4 za uporabo pri zdravljenju astme ali kronične obstruktivne pljučne bolezni.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08382040A EP2172190A1 (en) | 2008-10-02 | 2008-10-02 | Inhalable particles comprising tiotropium |
| US10411308P | 2008-10-09 | 2008-10-09 | |
| EP09783687.8A EP2349204B1 (en) | 2008-10-02 | 2009-10-02 | Inhalable particles comprising tiotropium |
| PCT/EP2009/062821 WO2010037845A1 (en) | 2008-10-02 | 2009-10-02 | Inhalable particles comprising tiotropium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2349204T1 true SI2349204T1 (sl) | 2018-08-31 |
Family
ID=40348057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200931854T SI2349204T1 (sl) | 2008-10-02 | 2009-10-02 | Delci za vdihavanje, ki vsebujejo tiotropij |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US20110311618A1 (sl) |
| EP (2) | EP2172190A1 (sl) |
| JP (1) | JP5622730B2 (sl) |
| KR (1) | KR101639089B1 (sl) |
| CN (1) | CN102170861B (sl) |
| AR (1) | AR073528A1 (sl) |
| AU (1) | AU2009299801B2 (sl) |
| BR (1) | BRPI0920706B8 (sl) |
| CA (1) | CA2737399C (sl) |
| CL (1) | CL2011000696A1 (sl) |
| CO (1) | CO6361899A2 (sl) |
| CR (1) | CR20110227A (sl) |
| CY (1) | CY1121090T1 (sl) |
| DK (1) | DK2349204T3 (sl) |
| DO (1) | DOP2011000091A (sl) |
| EC (1) | ECSP11010925A (sl) |
| ES (1) | ES2675857T3 (sl) |
| HN (1) | HN2011000864A (sl) |
| HR (1) | HRP20181009T1 (sl) |
| HU (1) | HUE038208T2 (sl) |
| LT (1) | LT2349204T (sl) |
| MA (1) | MA34560B1 (sl) |
| MX (1) | MX2011003491A (sl) |
| MY (1) | MY159172A (sl) |
| NI (1) | NI201100066A (sl) |
| NZ (1) | NZ591923A (sl) |
| PE (2) | PE20142435A1 (sl) |
| PL (1) | PL2349204T3 (sl) |
| PT (1) | PT2349204T (sl) |
| RU (2) | RU2011117256A (sl) |
| SI (1) | SI2349204T1 (sl) |
| SV (1) | SV2011003852A (sl) |
| TR (1) | TR201808269T4 (sl) |
| TW (1) | TWI433675B (sl) |
| UA (1) | UA100777C2 (sl) |
| UY (1) | UY32160A (sl) |
| WO (1) | WO2010037845A1 (sl) |
| ZA (1) | ZA201101735B (sl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012138909A (ru) * | 2010-03-31 | 2014-05-10 | Гленмарк Фармасьютикалс Лимитед | Фармацевтическая порошковая композиция для ингаляций |
| WO2011152804A2 (en) * | 2010-06-03 | 2011-12-08 | Mahmut Bilgic | Process for dry powder formulations |
| WO2011154014A1 (en) * | 2010-06-11 | 2011-12-15 | Gea Process Engineering A/S | Controlled humidity drying |
| ES2769576T3 (es) | 2010-08-23 | 2020-06-26 | Fraunhofer Ges Forschung | Partículas humidificadas que comprenden una sustancia terapéuticamente activa |
| WO2013109216A2 (en) * | 2012-01-16 | 2013-07-25 | Mahmut Bilgic | Preparation of dry powder formulations comprising tiotropium |
| DE102013012914A1 (de) | 2012-08-03 | 2014-02-20 | Gheorghe George Olaru | Hot runner injection molding apparatus with additional controller |
| EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
| CN105324106A (zh) | 2013-04-01 | 2016-02-10 | 普马特里克斯营业公司 | 噻托铵干粉 |
| KR101748796B1 (ko) * | 2015-09-30 | 2017-06-19 | 한미약품 주식회사 | 활성성분의 전달량이 향상된 흡입용 캡슐제 |
| EP4108230A1 (en) * | 2021-06-24 | 2022-12-28 | Laboratoires SMB | New dry powder composition of tiotropium for inhalation |
| GR1010358B (el) * | 2021-09-14 | 2022-12-16 | Elpen Ανωνυμος Εταιρεια Φαρμακευτικη Βιομηχανια, | Σταθερο φαρμακευτικο σκευασμα που περιεχει βρωμιουχο τιοτροπιο, για χορηγηση απο το αναπνευστικο |
| CN114191418B (zh) * | 2021-12-21 | 2023-06-09 | 丽珠医药集团股份有限公司 | 噻托溴铵双层微球及其制备方法和噻托溴铵缓释吸入剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| CA2347856C (en) * | 1998-11-13 | 2009-02-17 | Jago Research Ag | Dry powder for inhalation |
| US20020081266A1 (en) * | 1999-08-20 | 2002-06-27 | Norton Healthcare Ltd. | Spray dried powders for pulmonary or nasal administration |
| KR100488644B1 (ko) | 2000-10-12 | 2005-05-11 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 티오트로퓸을 함유하는 신규 흡입용 산제 |
| PT1591121E (pt) * | 2000-12-14 | 2009-07-20 | Ortho Mcneil Janssen Pharm | Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina |
| US6485279B2 (en) * | 2000-12-26 | 2002-11-26 | Carrier Corporation | Thrust load reliever |
| DE10126924A1 (de) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalationskapseln |
| ES2718455T3 (es) * | 2002-03-20 | 2019-07-02 | Civitas Therapeutics Inc | Formulaciones terapéuticas sostenidas inhalables |
| US7754242B2 (en) * | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| DE10339197A1 (de) * | 2003-08-22 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität |
| PT1869035E (pt) * | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| EP1976486A1 (en) * | 2006-01-27 | 2008-10-08 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A method of producing porous microparticles |
| GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| GB0801876D0 (en) * | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
-
2008
- 2008-10-02 EP EP08382040A patent/EP2172190A1/en not_active Withdrawn
-
2009
- 2009-09-30 AR ARP090103794A patent/AR073528A1/es not_active Application Discontinuation
- 2009-10-01 TW TW098133428A patent/TWI433675B/zh active
- 2009-10-02 NZ NZ591923A patent/NZ591923A/en unknown
- 2009-10-02 AU AU2009299801A patent/AU2009299801B2/en active Active
- 2009-10-02 MX MX2011003491A patent/MX2011003491A/es active IP Right Grant
- 2009-10-02 UA UAA201105365A patent/UA100777C2/ru unknown
- 2009-10-02 HU HUE09783687A patent/HUE038208T2/hu unknown
- 2009-10-02 MA MA33805A patent/MA34560B1/fr unknown
- 2009-10-02 PE PE2014002239A patent/PE20142435A1/es active IP Right Grant
- 2009-10-02 JP JP2011529566A patent/JP5622730B2/ja active Active
- 2009-10-02 CN CN200980138843.5A patent/CN102170861B/zh active Active
- 2009-10-02 LT LTEP09783687.8T patent/LT2349204T/lt unknown
- 2009-10-02 MY MYPI2011001426A patent/MY159172A/en unknown
- 2009-10-02 PE PE2011000799A patent/PE20110850A1/es not_active Application Discontinuation
- 2009-10-02 PT PT97836878T patent/PT2349204T/pt unknown
- 2009-10-02 CA CA2737399A patent/CA2737399C/en active Active
- 2009-10-02 WO PCT/EP2009/062821 patent/WO2010037845A1/en active Application Filing
- 2009-10-02 EP EP09783687.8A patent/EP2349204B1/en active Active
- 2009-10-02 US US13/122,134 patent/US20110311618A1/en not_active Abandoned
- 2009-10-02 TR TR2018/08269T patent/TR201808269T4/tr unknown
- 2009-10-02 DK DK09783687.8T patent/DK2349204T3/en active
- 2009-10-02 ES ES09783687.8T patent/ES2675857T3/es active Active
- 2009-10-02 KR KR1020117010097A patent/KR101639089B1/ko active IP Right Grant
- 2009-10-02 RU RU2011117256/15A patent/RU2011117256A/ru unknown
- 2009-10-02 BR BRPI0920706A patent/BRPI0920706B8/pt active IP Right Grant
- 2009-10-02 PL PL09783687T patent/PL2349204T3/pl unknown
- 2009-10-02 UY UY0001032160A patent/UY32160A/es active IP Right Grant
- 2009-10-02 RU RU2014150986A patent/RU2685236C2/ru active
- 2009-10-02 SI SI200931854T patent/SI2349204T1/sl unknown
-
2011
- 2011-03-07 ZA ZA2011/01735A patent/ZA201101735B/en unknown
- 2011-03-07 SV SV2011003852A patent/SV2011003852A/es unknown
- 2011-03-29 EC EC2011010925A patent/ECSP11010925A/es unknown
- 2011-03-30 CL CL2011000696A patent/CL2011000696A1/es unknown
- 2011-03-31 HN HN2011000864A patent/HN2011000864A/es unknown
- 2011-04-01 DO DO2011000091A patent/DOP2011000091A/es unknown
- 2011-04-01 NI NI201100066A patent/NI201100066A/es unknown
- 2011-04-29 CR CR20110227A patent/CR20110227A/es unknown
- 2011-04-29 CO CO11052660A patent/CO6361899A2/es not_active Application Discontinuation
-
2018
- 2018-06-28 HR HRP20181009TT patent/HRP20181009T1/hr unknown
- 2018-07-04 CY CY181100703T patent/CY1121090T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2349204T1 (sl) | Delci za vdihavanje, ki vsebujejo tiotropij | |
| CA2857980C (en) | Dry powder formulation of azole derivative for inhalation | |
| JP7048642B2 (ja) | 肺、鼻、舌下および／または咽頭への送達に適した、少なくとも１つの生物活性化合物をロードした多孔質シリカ粒子の製造方法 | |
| JP2016512494A5 (sl) | ||
| PT2398464T (pt) | Composição farmacêutica para inalação | |
| JP2012517987A5 (ja) | 吸入用の医薬組成物のｆｐｄ特性を設定する方法 | |
| JP2020518620A5 (sl) | ||
| Levet et al. | Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties | |
| PT109030B (pt) | Preparação de partículas inaláveis de zafirlucaste | |
| EP2320873A1 (en) | Telmisartan tablets | |
| JP2017508776A (ja) | 医薬品有効成分吸入用の噴霧乾燥した水中油中固体分散体 | |
| CN104644618A (zh) | 一种干粉吸入剂及其制备方法 | |
| RU2016107798A (ru) | Ингалируемые частицы, содержащие тиотропий и индакатерол | |
| EA035740B1 (ru) | Состав для повышения стабильности лекарственного препарата, содержащий по меньшей мере один сухой порошок, полученный распылительной сушкой | |
| KR20220149669A (ko) | 엔시펜트린 및 글리코피롤레이트를 포함하는 액상 약제학적 조성물 | |
| PT2821061T (pt) | Novas formulações para inalação | |
| CN107184555B (zh) | 一种盐酸丙卡特罗颗粒剂 | |
| Barazesh et al. | The effect of metal salts on aerosol performance of spray dried carrier-free formulations of levofloxacin | |
| HRP20231364T1 (hr) | Pedijatrijski prah za oralnu suspenziju koji sadrži antivirusno sredstvo i postupak za njegovu pripremu | |
| Dutton et al. | Development of an inhaled ion-paired salbutamol formulation | |
| TR201721968A2 (tr) | İyi̇leşti̇ri̇lmi̇ş bi̇r i̇laç dağilimina sahi̇p ti̇otropi̇um bromür i̇çeren kuru toz i̇nhaler üreti̇m yöntemi̇ |